nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naïve cells and memory subsets
|
Pojero, Fanny |
|
2016 |
49 |
C |
p. 51-59 9 p. |
artikel |
2 |
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
|
Gerrard, Gareth |
|
2016 |
49 |
C |
p. 47-50 4 p. |
artikel |
3 |
CIK immunotherapy in refractory hematologic malignancies
|
Wong, Eric |
|
2016 |
49 |
C |
p. 60-61 2 p. |
artikel |
4 |
Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study
|
Jastaniah, Wasil |
|
2016 |
49 |
C |
p. 66-72 7 p. |
artikel |
5 |
Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma
|
Moon, Joon-Ho |
|
2016 |
49 |
C |
p. 80-87 8 p. |
artikel |
6 |
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies
|
Norsworthy, Kelly J. |
|
2016 |
49 |
C |
p. 90-97 8 p. |
artikel |
7 |
Editorial board and publication information
|
|
|
2016 |
49 |
C |
p. IFC- 1 p. |
artikel |
8 |
IRE1α-XBP1 signaling pathway, a potential therapeutic target in multiple myeloma
|
Chen, Lin |
|
2016 |
49 |
C |
p. 7-12 6 p. |
artikel |
9 |
MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma
|
Li, Yanjie |
|
2016 |
49 |
C |
p. 73-79 7 p. |
artikel |
10 |
Myelodysplastic syndrome after breast cancer. The challenge of late complications in long-term survivors
|
Font, Patricia |
|
2016 |
49 |
C |
p. 88-89 2 p. |
artikel |
11 |
New drugs for follicular lymphoma
|
Sorigue, Marc |
|
2016 |
49 |
C |
p. 38-46 9 p. |
artikel |
12 |
New monoclonal antibodies for the treatment of acute lymphoblastic leukemia
|
Farhadfar, Nosha |
|
2016 |
49 |
C |
p. 13-21 9 p. |
artikel |
13 |
PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma
|
Crescenzi, Anna |
|
2016 |
49 |
C |
p. 98-101 4 p. |
artikel |
14 |
Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission
|
Sun, Yanjun |
|
2016 |
49 |
C |
p. 102-107 6 p. |
artikel |
15 |
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
|
Ghobadi, Armin |
|
2016 |
49 |
C |
p. 1-6 6 p. |
artikel |
16 |
Prof. Thomas Büchner (22 September 1934–5 August 2016). A career devoted to research in acute myeloid leukaemia
|
Gale, Robert Peter |
|
2016 |
49 |
C |
p. 113-114 2 p. |
artikel |
17 |
Pushing the boundaries of care in myelodysplastic syndromes: Physical exercise to improve fatigue and health-related quality of life outcomes
|
Efficace, Fabio |
|
2016 |
49 |
C |
p. 36-37 2 p. |
artikel |
18 |
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL135INS
|
Berman, Ellin |
|
2016 |
49 |
C |
p. 108-112 5 p. |
artikel |
19 |
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia
|
Watts, Justin M. |
|
2016 |
49 |
C |
p. 62-65 4 p. |
artikel |
20 |
The metabolomic signature of hematologic malignancies
|
Allegra, Alessandro |
|
2016 |
49 |
C |
p. 22-35 14 p. |
artikel |